Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 249

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression

Frye, Mark A., Grunze, Heinz, Suppes, Trisha, McElroy, Susan L., Keck, Paul E., Walden, Jorge, Leverich, Gabriele S., Altshuler, Lori L., Nakelsky, Shoshanna, Hwang, Sun, Mintz, Jim, Post, Robert M. · 2007 · American Journal of Psychiatry

Abstract

OBJECTIVE: Modafinil is approved by the U.S. Food and Drug Administration for improving wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift-work sleep disorder. This study was conducted to evaluate the efficacy and safety of adjunctive modafinil in bipolar depression, which is often characterized by excessive sleepiness and fatigue. METHOD: Eighty-five patients with bipolar depression that was inadequately responsive to a mood stabilizer with or without concomitant antidepressant therapy were randomly assigned to receive adjunctive modafinil (N=41) or placebo (N=44) for 6 weeks. The primary outcome measure was baseline-to-endpoint change in score on the Inventory of Depressive Symptoms--Clinician Rated (IDS). RESULTS: The baseline-to-endpoint change in IDS score was significantly greater in the modafinil group (mean dose, 177 mg/day) compared with the placebo group. Improvement in depressive symptoms was significantly greater in the modafinil group by week 2, and this greater improvement was maintained at weeks 4, 5, and 6. Both the response and remission rates were significantly higher in the modafinil group (44% and 39%) compared with the placebo group (23% and 18%). During the 6-week study period, there was no difference between groups in treatment-emergent hypomania or mania (six patients in the modafinil group and five in the placebo group) or hospitalization for mania (one in each group). CONCLUSIONS: These data suggest that adjunctive modafinil at doses of 100-200 mg a day may improve depressive symptoms in patients with bipolar disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2007.06060981

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 33

  1. 10.1002/ana.410430115 · DOI · Paper page
  2. 10.1212/WNL.54.5.1166 · DOI · Paper page
  3. 10.1136/jnnp.2005.065870 · DOI · Paper page
  4. 10.1136/jnnp.72.2.179 · DOI · Paper page
  5. 10.1016/S0304-3940(97)00962-2 · DOI
  6. 10.1007/s00213-002-1080-8 · DOI
  7. 10.1080/10401230490453743 · DOI
  8. 10.1542/peds.2005-0617 · DOI
  9. 10.4088/JCP.v67n0120 · DOI
  10. 10.4088/JCP.v64n0911 · DOI · Paper page
  11. 10.4088/JCP.v66n0112 · DOI · Paper page
  12. 10.4088/JCP.v65n0318 · DOI
  13. 10.1017/S1092852900010622 · DOI
  14. 10.1002/da.20013 · DOI
  15. 10.1176/appi.ajp.158.6.906 · DOI · Paper page
  16. 10.4088/JCP.v63n0607 · DOI · Paper page
  17. 10.1097/00004850-198910000-00006 · DOI · Paper page
  18. Himmelhoch JM, 1991, Am J Psychiatry, 7, 910
  19. 10.1176/ajp.157.1.124 · DOI · Paper page
  20. Sachs GS, 1994, J Clin Psychiatry, 9, 391
  21. 10.1016/j.biopsych.2004.03.013 · DOI · Paper page
  22. 10.1176/appi.ajp.161.3.564 · DOI · Paper page
  23. First MB, 1996, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-I)
  24. 10.1016/0165-1781(86)90060-0 · DOI · Paper page
  25. 10.1016/S0165-0327(01)00430-X · DOI · Paper page
  26. 10.1016/S0165-1781(97)00123-6 · DOI · Paper page
  27. 10.1001/archneur.1989.00520460115022 · DOI · Paper page
  28. 10.1016/S0165-0327(99)00055-5 · DOI · Paper page
  29. 10.1007/s00213-002-1250-8 · DOI · Paper page
  30. 10.1038/sj.npp.1300457 · DOI · Paper page
  31. 10.1192/bjp.187.1.55 · DOI
  32. 10.1073/pnas.93.24.14128 · DOI · Paper page
  33. 10.1176/appi.ajp.161.9.1537 · DOI · Paper page

Cited by

See all 249

Metadata

Authors
Frye, M. A., Grunze, H., Suppes, T., McElroy, S. L., Keck, P. E., Walden, J., Leverich, G. S., Altshuler, L. L., Nakelsky, S., Hwang, S., Mintz, J., & Post, R. M.
Venue
American Journal of Psychiatry
Published
2007-08
Volume
164
Issue
8
Pages
1242-1249
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W1989320794
Cited by
249
References
13
FWCI
14.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression. https://app.cochat.ai/papers/10.1176/appi.ajp.2007.06060981
The paper
Frye, M. A., Grunze, H., Suppes, T., McElroy, S. L., Keck, P. E., Walden, J., Leverich, G. S., Altshuler, L. L., Nakelsky, S., Hwang, S., Mintz, J., & Post, R. M. (2007). A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2007.06060981

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.